<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Q-VD-Oph_Principals_Described</id>
		<title>Q-VD-Oph Principals Described - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Q-VD-Oph_Principals_Described"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Q-VD-Oph_Principals_Described&amp;action=history"/>
		<updated>2026-04-10T07:09:14Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Q-VD-Oph_Principals_Described&amp;diff=93397&amp;oldid=prev</id>
		<title>Nylon8string : Page créée avec « In addition, ER-negative tumors were subdivided on the basis of their AR status [25], and cytokeratin 5/6 (CK5/6) staining was employed as a marker of basal-type tumors. F... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Q-VD-Oph_Principals_Described&amp;diff=93397&amp;oldid=prev"/>
				<updated>2017-04-24T05:48:40Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « In addition, ER-negative tumors were subdivided on the basis of their AR status [25], and cytokeratin 5/6 (CK5/6) staining was employed as a marker of basal-type tumors. F... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;In addition, ER-negative tumors were subdivided on the basis of their AR status [25], and cytokeratin 5/6 (CK5/6) staining was employed as a marker of basal-type tumors. Furthermore, we obtained IHC scores for PIP on the basis of the percentage and intensity of staining for this protein in each tumor (Figure?2, A and B). Next, we assessed the association of PIP expression with biomarkers and molecular subtypes. We observed that AR-positive tumors have a significantly higher PIP expression compared to AR negatives (P [http://www.selleckchem.com/products/bay-61-3606.html BAY-61-3606 purchase] tumors, PIP expression was associated with AR-positive status and was unrelated to CK5/6 staining ( Figure?2D). It is notable that PIP expression was not associated with either tumor [http://www.selleckchem.com/products/q-vd-oph.html Selleck QVDOph] size or grade in this cohort (P &amp;gt; .1). These findings suggest that PIP is widely expressed in luminal A, luminal B, and ER??/AR?+ (molecular apocrine) subtypes of breast cancer. Moreover, PIP expression is associated with AR and is present in both luminal and basal ER-negative tumors. To investigate the functional role of PIP in breast cancer, we carried out a nonbiased genomic approach to study the transcriptional signature of this gene using a microarray data set of 52 breast cancer cell lines [21]. To identify PIP coregulated genes, we first [http://en.wikipedia.org/wiki/Thymidine_kinase Thymidine kinase] calculated the Pearson CC for each gene expression in the data set with that of PIP and then obtained the list of genes that had Pearson CC values ��?0.5 (P&lt;/div&gt;</summary>
		<author><name>Nylon8string</name></author>	</entry>

	</feed>